Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis

Atherosclerosis is the main underlying cause of cardiovascular diseases (CVDs), which remain the number one contributor to mortality worldwide. Although current therapies can slow down disease progression, no treatment is available that can fully cure or reverse atherosclerosis. Nanomedicine, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Linsey J. F., Jans, Alexander, Bartneck, Matthias, van der Vorst, Emiel P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306310/
https://www.ncbi.nlm.nih.gov/pubmed/34300351
http://dx.doi.org/10.3390/jcm10143185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306310/
https://www.ncbi.nlm.nih.gov/pubmed/34300351
http://dx.doi.org/10.3390/jcm10143185

Ejemplares similares